| Product Name | MF | CAS | Details |
|---|
| 2-(chloromethyl) methyl acrylate | C5H7ClO2 | 922-15-6 | Details |
| Cis-9, 10-methyleneoctadecanoic acid | C19H36O2 | 4675-61-0 | Details |
| 2-methyl-2-propyl (4-hydroxy-1-methylcyclohexyl) carbamate | C12H23NO3 | 792913-83-8 | Details |
| 4-bromo-2-ethylpyridine | C7H8BrN | 156761-88-5 | Details |
| 2-amino-naphthalene intercalated diazine (heterobenzene) hydrogen chloride | C11H10BrN3 | 40835-96-9 | Details |
| 2-bromo-4,5,6, 7-tetrahydro1-benzothiophene | C8H9BrS | 111873-07-5 | Details |
| 5-chloro-7-nitro-indole | C8H5ClN2O2 | 1197181-29-5 | Details |
| 8-chlorobenzopyran | C9H9ClO | 3722-69-8 | Details |
| 3-phenoxypropylamine | C9H13NO | 7617-76-7 | Details |
| Glycine, N, N '- [1 - (4, 5 - dimethoxy - 2 - nitro phenyl) - 1, 2 - ethyl 2 base] double [N - (carboxymethyl) - four sodium salt (cl) | C18H24N3NaO12 | 291517-40-3 | Details |
| 2, 4-dimethoxy-N -(3-thiazolo-[5, 4-b] pyridine-2-phenyl) benzamide | C21H17N3O3S | 863589-44-0 | Details |
| 3-bromo-methyl-4-bromo-benzoate | C9H8Br2O2 | 142031-67-2 | Details |
| 3-[(4-chlorophenyl) sulfonyl] azacyclobutane hydrochloride | C9H11Cl2NO2S | 1820665-00-6 | Details |
| 3-bromo-7-hydroxy-1-naphthonitrile | C11H6BrNO | 550998-30-6 | Details |
| N1-(3-amino-propyl) pentane-1, 5-diamine 3HCL | C8H22ClN3 | 90532-85-7 | Details |
| 3-(aminomethyl) pyrazole | C4H7N3 | 37599-58-9 | Details |
| 6-amino-1-indone | C9H9NO | 69975-65-1 | Details |
| 3-ethyloxacyclophane-3-formaldehyde | C6H10O2 | 98485-37-1 | Details |
| 3-hydroxy-5-methoxybenzoic acid | C8H8O4 | 19520-75-3 | Details |
| 7-chloro-1h-indazole-6-amine | C7H6ClN3 | 112635-08-2 | Details |
| 3-bromo-2-furanoic acid | C5H3BrO3 | 14903-90-3 | Details |
| Cis-trans-muconic acid | C6H6O4 | 1119-73-9 | Details |
| N, n-dimethyl methylamine iodide | C3H8IN | 33797-51-2 | Details |
| Upatinib Impurity 93 | C16H21NO3 | 2411540-29-7 | Details |
| Olanzapine impurity Q | C17H20N4O2S | 1320360-87-9 | Details |
| Olanzapine impurity R | C15H18N4OS | 1320360-86-8 | Details |
| C47H68O5 | Details |
| C25H38O4 | Details |
| C20H34O2 | C20H34O2 | 1191-41-9 | Details |
| C69H98O6 | Details |
| Moxidectin EP Impurity K | C44H56N2O11 | 174756-99-1 | Details |
| Cilnidipine Impurity 16 | C32H41N5O5 | 205448-66-5 | Details |
| Bromocriptine EP Impurity G | C32H40BrN5O5 | Details |
| Bromocriptine | C32H40BrN5O5 | 25614-03-3 | Details |
| Bromocriptine EP Impurity D | C16H15BrN2O2 | 478-83-1 | Details |
| Bromocriptine EP Impurity C | C32H40BrN5O5 | 65700-36-9 | Details |
| Bromocriptine EP Impurity F | C32H40BrN5O5 | 82773-21-5 | Details |
| Bromocriptine EP Impurity A | C32H40BrN5O5 | Details |
| Bromocriptine Impurity 10 | C32H40BrN5O5 | Details |
| Bromocriptine Impurity 12 | C33H42BrN5O5 | Details |
| Bromocriptine N-Oxide | Details |
| Bromocriptine Impurity 9 | Details |
| Valsartan Methyl Ester | C33H44BrN5O8S | 22260-51-1 | Details |
| 2-methyl-3-((7S,11S,Z)-3,7,11,15-tetramethylhexadec-2-en-1-yl)naphthalene-1,4-dione | Details |
| (E)-2-methyl-3-(3,7,11,15-tetramethylhexadec-1-en-1-yl)naphthalene-1,4-dione | Details |
| 2-methyl-3-((7R,11S,Z)-3,7,11,15-tetramethylhexadec-2-en-1-yl)naphthalene-1,4-dione | Details |
| Vitamin K1 cis-isomer | C31H46O2 | 16033-41-3 | Details |
| Vitamin K1 impurity 6 | C11H8O3 | 15448-59-6 | Details |
| Vitamin K1 impurity 5 | C31H46O2 | 34044-00-3 | Details |
| Vitamin K1 Impurity 7 | C31H46O3 | 25486-55-9 | Details |
| Vitamin K1(7S,11R,E) isomer | C31H46O2 | 132487-95-7 | Details |
| Vitamin K1 Impurity 1 | C31H46O3 | 15576-40-6 | Details |
| 2-methyl-3-((7S,11R,Z)-3,7,11,15-tetramethylhexadec-2-en-1-yl)naphthalene-1,4-dione | Details |
| Vitamin K1(7S,11S,E) isomer | C31H46O2 | 132487-94-6 | Details |
| 2-methyl-5-methylene-2-((4R,8R)-4,8,12-trimethyltridecyl)-2H-benzo[h]chromen-6(5H)-one | C31H48O2 | 64236-23-3 | Details |
| (E)-2-(3-hydroxy-3,7,11,15-tetramethylhexadec-1-en-1-yl)-3-methylnaphthalene-1,4-dione | C13H12O3 | 2211-27-0 | Details |
| Vitamin K1 impurity 3 | C18H36O | 502-69-2 | Details |
| Vitamin K1 Impurity 4 | C11H8O3 | 483-55-6 | Details |
| Vitamin K1(7R,11S,E) isomer | C31H46O2 | 132487-93-5 | Details |
| Ropiniero hydrochloride | C16H25ClN2O | 91374-20-8 | Details |
| Ropiniero EP Impurity B(hydrochloride) | C16H25ClN2O | 221264-33-1 | Details |
| 4-(2-((2-methylpentyl)amino)ethyl)indolin-2-one | C16H24N2O | 249622-60-4 | Details |
| Ropiniero EP Impurity A(hydrochloride) | C16H23ClN2O2 | 221264-21-7 | Details |
| Ropiniero nitrogen oxide. | C16H24N2O2 | 1076199-41-1 | Details |
| Ropiniero EP Impurity D(hydrochloride) | C13H19ClN2O | 173990-76-6 | Details |
| Ropiniero EP Impurity C(hydrochloride) | C19H29ClN2O | 145570-92-9 | Details |
| Ropiniero EP Impurity D | C13H18N2O | 106916-16-9 | Details |
| 4-(2-(dipropylamino)ethyl)-3-methyleneindolin-2-one hydrochloride | Details |
| Ropinirole EP Impurity F | C10H11NO2 | 139122-19-3 | Details |
| Ropinirole Impurity 8 | C17H26N2O2 | 1027600-42-5 | Details |
| Ropiniero EP Impurity G | C16H24N2 | 76149-15-0 | Details |
| Ropinirole Impurity 10 | C10H10ClNO | 168476-59-3 | Details |
| 4-(2-(dipropylamino)ethyl)-3-methyleneindolin-2-one | Details |
| 6-hydroxy-1-(4-(4-hydroxyphenyl)butan-2-yl)-1H-indol-5(7aH)-one | Details |
| Empagliflozin Impurity 133 | C23H27BrO7 | 2452301-12-9 | Details |
| Vericiguat Impurity | C19H16F2N8O2 | 1350653-20-1 | Details |
| Lactate tetramer | C20H24N2O6 | 1985607-65-5 | Details |
| Linagliptin Impurity 45 | C21H21N7O2 | 2468656-63-3 | Details |
| Upadacitinib Impurity 4 | C34H39N5O7S | 1428243-27-9 | Details |
| Linagliptin Impurity CD10100 | C16H20BrNO3 | 2304514-69-8 | Details |
| 7-((3R,5R)-3-amino-5-methylpiperidin-1-yl)-1-cyclopropyl-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | C20H25N3O4 | 378746-65-7 | Details |
| Phloroglucinol Impurity 13 | C7H6Br2O | 74137-36-3 | Details |
| Caspofungin Impurity 26 | Details |
| Verapamil EP Impurity P (Mixture of Diastereomers) | C29H38N2O4 | 2086275-13-8 | Details |
| I030004 | C19H18N4O3S | 172152-37-3 | Details |
| Upadacitinib Impurity 7 | C14H17N5 | 1708997-43-6 | Details |
| Bisoprolol Impurity 9 | C16H25NO5 | 1346602-59-2 | Details |
| Linagliptin Impurity CD10102 | C11H9N3O | 1018229-53-2 | Details |
| Phthalamic Acid | C19H18N4OS | 172152-35-1 | Details |
| Ilaprazole Impurity 16 | C27H27N5O2S | 1360824-56-1 | Details |
| Sugammadex sodium Decomposition process Impurity 3 | C6H10O4S2 | 1119-62-6 | Details |
| Oseltamivir impurity 130 | C14H24O5 | 2097777-49-4 | Details |
| Nemonoxacin Impurity 6 | C12H12F2O4 | 221221-12-1 | Details |
| Upatinib impurity 46 | C13H12N4O2S | 1201187-46-3 | Details |
| Tofacitinib Citrate | C20H21F6N7O2 | 2715120-86-6 | Details |
| Cytarabine impurity 7 | C17H19N5O8 | 82855-62-7 | Details |
| Tafluprost Impurity E | C25H34F2O5 | 1563176-58-8 | Details |
| Tafluprost Impurity 3 | C23H24BrO2P | 17814-85-6 | Details |
| Verapamil EP Impurity C HCl | C12H20ClNO2 | 51012-67-0 | Details |
| Baloxavir Impurity 79. | C14H10F2O2S | 2757707-17-6 | Details |
| Product Total： Product Page： | ||||
| 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 | ||||